Human Molecular Genetics Advance Access originally published online on January 31, 2006
Human Molecular Genetics 2006 15(6):883-895; doi:10.1093/hmg/ddl006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Parkin enhances mitochondrial biogenesis in proliferating cells
1Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan and 2General Laboratory for Medical Research, University of Tokushima Graduate School of Medicine, Kuramoto-3, Tokushima 770-8503, Japan
* To whom correspondence should be addressed. Tel: +81 886337120; Fax: +81 886337121; Email: tmitsui{at}clin.med.tokushima-u.ac.jp
Received October 28, 2005; Accepted January 25, 2006
We describe a novel function of parkin, a RING protein, which is elaborately involved in mitochondrial biogenesis. Parkin was located within the mitochondrial organelle of proliferating cells. Anti-proliferative treatments released parkin from mitochondria to cytosol. Results of pharmacological treatments indicate that parkin was released from mitochondria when permeability transition pore was opened. The extra-mitochondrial localization was also observed in differentiated cells. In proliferating cells, transcription and replication of mitochondrial DNA was enhanced by parkin overexpression and attenuated by parkin suppression with siRNA. Parkin was associated with mitochondrial transcription factor A (TFAM) and enhanced TFAM-mediated mitochondrial transcription. These results indicate that parkin is involved in the regulation of mitochondrial transcription/replication other than the ubiquitin-mediated protein degradation system in proliferating cells.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. E. Haque, K. J. Thomas, C. D'Souza, S. Callaghan, T. Kitada, R. S. Slack, P. Fraser, M. R. Cookson, A. Tandon, and D. S. Park Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP PNAS, February 5, 2008; 105(5): 1716 - 1721. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Scheele, A. R. Nielsen, T. B. Walden, D. A. Sewell, C. P. Fischer, R. J. Brogan, N. Petrovic, O. Larsson, P. A. Tesch, K. Wennmalm, et al. Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration? FASEB J, November 1, 2007; 21(13): 3653 - 3665. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Thomas and M. F. Beal Parkinson's disease Hum. Mol. Genet., October 15, 2007; 16(R2): R183 - R194. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Stichel, X.-R. Zhu, V. Bader, B. Linnartz, S. Schmidt, and H. Lubbert Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage Hum. Mol. Genet., October 15, 2007; 16(20): 2377 - 2393. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. KRISHNAN, L. C. GREAVES, A. K. REEVE, and D. M. TURNBULL Mitochondrial DNA Mutations and Aging Ann. N.Y. Acad. Sci., April 1, 2007; 1100(1): 227 - 240. [Abstract] [Full Text] [PDF] |
||||



